AAAAAA
Results: 1-25/33
Authors:
Rodvold, DM
McLeod, DG
Brandt, JM
Snow, PB
Murphy, GP
Citation: Dm. Rodvold et al., Introduction to artificial neural networks for physicians: Taking the lid off the black box, PROSTATE, 46(1), 2001, pp. 39-44
Authors:
Tjoa, BA
Murphy, GP
Citation: Ba. Tjoa et Gp. Murphy, Development of dendritic cell-based prostate cancer vaccine, CONT CANC R, 2001, pp. 449-459
Authors:
Elgamal, AAA
Holmes, EH
Su, SL
Tino, WT
Simmons, SJ
Peterson, M
Greene, TC
Boynton, AL
Murphy, GP
Citation: Aaa. Elgamal et al., Prostate-specific membrane antigen (PSMA): Current benefits and future value, SEM SURG ON, 18(1), 2000, pp. 10-16
Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction
Authors:
Su, SL
Boynton, AL
Holmes, EH
Elgamal, AAA
Murphy, GP
Citation: Sl. Su et al., Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction, SEM SURG ON, 18(1), 2000, pp. 17-28
Authors:
Tjoa, BA
Murphy, GP
Citation: Ba. Tjoa et Gp. Murphy, Progress in active specific immunotherapy of prostate cancer, SEM SURG ON, 18(1), 2000, pp. 80-87
Authors:
Tino, WT
Huber, MJ
Lake, TP
Greene, TG
Murphy, GP
Holmes, EH
Citation: Wt. Tino et al., Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA), HYBRIDOMA, 19(3), 2000, pp. 249-257
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Rogers, MK
Kenny, GM
Jarisch, J
Citation: Gp. Murphy et al., Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients, PROSTATE, 43(1), 2000, pp. 59-62
Authors:
Murphy, GP
Elgamal, AAA
Troychak, MJ
Kenny, GM
Citation: Gp. Murphy et al., Follow-up ProstaScint (R) scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy, PROSTATE, 42(4), 2000, pp. 315-317
Authors:
Murphy, GP
Su, S
Jarisch, J
Kenny, GM
Citation: Gp. Murphy et al., Serum levels of PSMA, PROSTATE, 42(4), 2000, pp. 318-319
Authors:
Murphy, GP
Snow, PB
Brandt, J
Elgamal, A
Brawer, MK
Citation: Gp. Murphy et al., Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint (R) scintiscans, PROSTATE, 42(2), 2000, pp. 145-149
Authors:
Murphy, GP
Snow, P
Simmons, SJ
Tjoa, BA
Rogers, MK
Brandt, J
Healy, CG
Bolton, WE
Rodbold, D
Citation: Gp. Murphy et al., Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients, PROSTATE, 42(1), 2000, pp. 67-72
Authors:
Tjoa, BA
Murphy, GP
Citation: Ba. Tjoa et Gp. Murphy, Development of dendritic-cell based prostate cancer vaccine, IMMUNOL LET, 74(1), 2000, pp. 87-93
Authors:
Preston, DM
Levin, LI
Jacobson, DJ
Jacobsen, SJ
Rubertone, M
Holmes, E
Murphy, GP
Moul, JW
Citation: Dm. Preston et al., Prostate-specific antigen levels in young white and black men 20 to 45 years old, UROLOGY, 56(5), 2000, pp. 812-816
Authors:
Lodge, PA
Jones, LA
Bader, RA
Murphy, GP
Salgaller, ML
Citation: Pa. Lodge et al., Dendritic cell-based immunotherapy of prostate cancer: Immune monitoring of a phase II clinical trial, CANCER RES, 60(4), 2000, pp. 829-833
Authors:
Lodge, PA
Childs, RA
Monahan, SJ
McLean, JG
Sehgal, A
Boynton, AL
Salgaller, ML
Murphy, GP
Citation: Pa. Lodge et al., Expression and purification of prostate-specific membrane antigen in the baculovirus expression system and recognition by prostate-specific membrane antigen-specific T cells, J IMMUNOTH, 22(4), 1999, pp. 346-355
Authors:
Drachenberg, DE
Elgamal, AAA
Rowbotham, R
Peterson, M
Murphy, GP
Citation: De. Drachenberg et al., Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer, PROSTATE, 41(2), 1999, pp. 127-133
Authors:
Tjoa, BA
Simmons, SJ
Elgamal, A
Rogers, M
Ragde, H
Kenny, GM
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Ba. Tjoa et al., Follow-up evaluation of a phase II prostate cancer vaccine trial, PROSTATE, 40(2), 1999, pp. 125-129
Authors:
Simmons, SJ
Tjoa, BA
Rogers, M
Elgamal, A
Kenny, GM
Ragde, H
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Sj. Simmons et al., GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial, PROSTATE, 39(4), 1999, pp. 291-297
Authors:
Mettlin, C
Chesley, AE
Murphy, GP
Bartsch, G
Toi, A
Bahnson, R
Church, P
Citation: C. Mettlin et al., Association of free PSA percent, total PSA, age, and gland volume in the detection of prostate cancer, PROSTATE, 39(3), 1999, pp. 153-158
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Ragde, H
Rogers, M
Elgamal, A
Kenny, GM
Troychak, MJ
Salgaller, ML
Boynton, AL
Citation: Gp. Murphy et al., Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment, PROSTATE, 39(1), 1999, pp. 54-59
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Jarisch, J
Bowes, VA
Ragde, H
Rogers, M
Elgamal, A
Kenny, GM
Cobb, OE
Ireton, RC
Troychak, MJ
Salgaller, ML
Boynton, AL
Citation: Gp. Murphy et al., Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease, PROSTATE, 38(1), 1999, pp. 73-78
Authors:
Sehgal, A
Ricks, S
Warrick, J
Boynton, AL
Murphy, GP
Citation: A. Sehgal et al., Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells, ANTICANC R, 19(6B), 1999, pp. 4947-4953
Authors:
Tjoa, BA
Elgamal, AAA
Murphy, GP
Citation: Ba. Tjoa et al., Vaccine therapy for prostate cancer, UROL CLIN N, 26(2), 1999, pp. 365
Authors:
Murphy, GP
Citation: Gp. Murphy, Review of phase II hormone refractory prostate cancer trials, UROLOGY, 54(6A), 1999, pp. 19-21
Authors:
Peng, JR
Richards, DE
Hartley, NM
Murphy, GP
Devos, KM
Flintham, JE
Beales, J
Fish, LJ
Worland, AJ
Pelica, F
Sudhakar, D
Christou, P
Snape, JW
Gale, MD
Harberd, NP
Citation: Jr. Peng et al., 'Green revolution' genes encode mutant gibberellin response modulators, NATURE, 400(6741), 1999, pp. 256-261